Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influenza B: Prospects for the Development of Cross-Protective Vaccines

17 Jun 2022

Abstract excerpt

In this review, we analyze the epidemiological and ecological features of influenza B, one of the most common and severe respiratory infections. The review presents various strategies for cross-protective influenza B vaccine development, including recombinant viruses, virus-like particles, and recombinant proteins. We provide an overview of viral proteins as cross-protective vaccine targets, along with other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to Respiratory viral infections research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35746794
DOI: 10.3390/v14061323

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influenza B: Prospects for the Development of Cross-Protective VaccinesPMID 35746794Read ↗

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentSemantic proximity Read ↗

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of MiceSemantic proximity Read ↗

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesSemantic proximity Read ↗

Recombinant Influenza VaccinesSemantic proximity Read ↗

A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A VirusSemantic proximity Read ↗

Development of Cross-Protective Influenza A Vaccines Based on Cellular ResponsesSemantic proximity Read ↗

A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countriesSemantic proximity Read ↗

M2e-Based Influenza Vaccines with Nucleoprotein: A ReviewSemantic proximity Read ↗

Influenza vaccines: challenges and solutions.Semantic proximity Read ↗

Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza BSemantic proximity Read ↗

Alternative antiviral approaches to combat influenza A virus.Semantic proximity Read ↗

Cross-reactive human B cell and T cell epitopes between influenza A and B virusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.